Stock OXYGEN BIOTHERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Oxygen Biotherapeutics Inc Nasdaq

Equities

US69207P3082

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Oxygen Biotherapeutics Inc
03-28 Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-28 Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Oxygen Biotherapeutics Inc

23512.hE7zpXjwn8y9jHzXvvKTpnoYngmZk46gYh2PRVZH93M.zSyZ_Smo_oPP-Urg-aTR4SxN-m2s1enzU0T5IBcdoyLRC7XXQaCyhu3PKQ~f690b0a6130ba5e6073dc1bd1cfa3c5f

Upcoming events on Oxygen Biotherapeutics Inc

12/05/2024 Q1 2024 Earnings Release (Projected)
18/08/2024 Q2 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
25/03/2026 Q4 2025 Earnings Release (Projected)

Past events on Oxygen Biotherapeutics Inc

18/04/2024 15:00 Investor Meeting - Key Opinion Leader
28/03/2024 12:30 Q4 2023 Earnings Release
18/03/2024 22:00 ROTH Conference
06/03/2024 14:39 Technology and Heart Failure Therapeutics Conference
02/01/2024 Reverse Split: 1 of 80
29/11/2023 Extraordinary Shareholders Meeting
04/01/2023 Reverse Split: 1 of 20
01/04/2022 American College of Cardiology Meeting
31/03/2022 13:30 FY 2021 Earnings Release
04/01/2022 LifeSci Partners Corporate Access Event
16/11/2021 13:30 Q3 2021 Earnings Release
29/09/2021 18:35 Benziga Healthcare Small Cap Conference
13/09/2021 12:00 H.C. Wainwright Global Investment Conference
17/08/2021 13:00 Interim 2021 Earnings Release
16/08/2021 15:00 Investor Meeting - Key Opinion Leader
09/06/2021 Annual General Meeting
17/05/2021 22:15 Q1 2021 Earnings Release
31/03/2021 21:45 FY 2020 Earnings Release
09/03/2021 12:00 H.C. Wainwright Global Life Science Conference
21/01/2021 21:30 Acquisition of PH Precision Med by Tenax Therapeutics, Inc Management Discussion Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-9,86
-8,90
-10.83%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-8,56
-8,25
-3.7%		-9,87
-8,90
-10.88%		-32,7
-33,6
2.45%		-11,1
-12,0
7.92%		-8,23
-7,39
-11.47%
-16,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-8,39
-8,40
0.07%		-9,85
-8,90
-10.69%		-32,5
-33,5
2.92%		-11,0
-12,0
7.96%		-7,71
-7,18
-7.35%
-16,2

Net income
Million USD		Released
Forecast
Spread 		-8,39
-11,9
29.16%		-9,85
-8,90
-10.69%		-32,5
-33,5
2.92%		-11,0
-12,0
7.96%		-7,71
-7,18
-7.35%
-16,2

EPS
USD		Released
Forecast
Spread 		-2 160
-2 488
13.18%		-2 128
-1 352
-57.4%		-2 528
-2 600
2.77%		-601
-745
19.33%		-31,0
-28,8
-7.78%
-7,43

Announcement Date30/03/2031/03/2129/03/2231/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
-


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-3,21
-4,05
20.7%


-2,86
-2,50
-14.48%		-2,92
-3,25
10.23%		-2,55
-3,50
27.09%		-1,54
-2,63
41.53%		-1,24
-2,07
40.15%		-2,12
-2,60
18.56%		-3,34
-2,49
-34.15%
-3,51


-3,23


-3,64


-3,96

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-3,21
-4,05
20.73%


-2,86
-2,50
-14.44%		-2,92
-3,25
10.26%		-2,55
-3,50
27.25%		-1,41
-2,63
46.57%		-1,11
-2,07
46.44%		-1,97
-2,60
24.15%		-3,23
-2,49
-29.52%
-3,51


-3,23


-3,64


-3,96

Net income
Million USD		Released
Forecast
Spread 		-3,21
-4,05
20.73%		-2,72


-2,86
-2,50
-14.44%		-2,92
-3,25
10.26%		-2,55
-3,50
27.25%		-1,41
-2,63
46.57%		-1,11
-2,07
46.44%		-1,97
-2,60
24.15%		-3,23
-2,49
-29.52%
-3,51


-3,23


-3,64


-3,96

EPS
USD		Released
Forecast
Spread 		-64,0
-256
75%		-176


-176
-144
-22.22%		-176
-168
-4.76%		-72,8
-212
65.73%		-12,0
-29,6
59.46%		-4,00
-8,00
50%		-6,40
-9,60
33.33%		-8,64
-8,15
-6.08%
-2,40


-1,65


-1,77


-1,19

Announcement Date29/03/2216/05/2211/08/2210/11/2231/03/2315/05/2314/08/2313/11/2328/03/24----

Upcoming sector events for Oxygen Biotherapeutics Inc

12/05/2024 FORTREA HOLDINGS INC.: Q1 2024 Earnings Release
12/05/2024 AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release (Projected)
12/05/2024 PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release
12/05/2024 BIOMEA FUSION, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 BELITE BIO, INC: Q1 2024 Earnings Release
13/05/2024 POLARIS GROUP: Q1 2024 Earnings Release
13/05/2024 ABSCI CORPORATION: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
15/05/2024 REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected)
More events

Past sector events for Oxygen Biotherapeutics Inc

10/05/2024 12:00 HUMACYTE, INC.: Q1 2024 Earnings Release
09/05/2024 NOVAVAX, INC.: Q1 2024 Earnings Release
09/05/2024 TAKARA BIO INC.: Q4 2023 Earnings Release
09/05/2024 CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected)
09/05/2024 21:10 GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 HILLEVAX, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 BIOHAVEN LTD.: Q1 2024 Earnings Release
09/05/2024 21:05 OMNIAB, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. TENX Stock
  4. Stock
  5. Calendar Oxygen Biotherapeutics Inc